Cargando…
Silencing of XB130 Is Associated with Both the Prognosis and Chemosensitivity of Gastric Cancer
XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patien...
Autores principales: | Shi, Min, Huang, Weizhen, Lin, Li, Zheng, Dayong, Zuo, Qiang, Wang, Lin, Wang, Nina, Wu, Yajun, Liao, Yulin, Liao, Wangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426513/ https://www.ncbi.nlm.nih.gov/pubmed/22927913 http://dx.doi.org/10.1371/journal.pone.0041660 |
Ejemplares similares
-
XB130 promotes proliferation and invasion of gastric cancer cells
por: Shi, Min, et al.
Publicado: (2014) -
XB130 is overexpressed in prostate cancer and involved in cell growth and invasion
por: Chen, Bin, et al.
Publicado: (2016) -
Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma
por: Poosekeaw, Pirawan, et al.
Publicado: (2021) -
Roles of XB130, a novel adaptor protein, in cancer
por: Shiozaki, Atsushi, et al.
Publicado: (2011) -
MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
por: Duan, Jiangman, et al.
Publicado: (2017)